Clinical Trial Update: Clinical Efficacy of Trastuzumab in Combination With Capecitabine and Oxaliplatin for the Treatment of HER2-positive Advanced Gastric Cancer. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating trastuzumab combined with capecitabine and oxaliplatin for HER2-positive advanced gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Advanced Gastric Carcinoma | Phase 2 | Status: COMPLETED